1. Corporate Officers - A
2. Andrews Ronald Asbury

Insider Trading History of Andrews Ronald Asbury

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Andrews Ronald Asbury since 2018. This trader's CIK number is 1299153. At the time of last reporting, Andrews Ronald Asbury was the Officer of Plus Therapeutics, Inc.. (stock ticker symbol PSTV). Also see all insider trading activities at Plus Therapeutics, Inc..

Note that in the past ANDREWS RONALD ASBURY also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Insight Molecular Diagnostics Inc. (OCX) by Andrews Ronald Asbury

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	OCX	90,000	$102,549	0	$0	250,000	$0
2021	OCX	11,000	$52,701	0	$0	65,000	$0
2020	OCX	85,216	$42,811,333	0	$0	0	$0
2018	OCX	17,482	$0	0	$0	0	$0

Yearly summary of insider trading at Plus Therapeutics, Inc. (PSTV) by Andrews Ronald Asbury

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	PSTV	0	$0	0	$0	922	$0

Insider trading activities at 2 companies by Andrews Ronald Asbury:

1. Insight Molecular Diagnostics Inc. (OCX)

2. Plus Therapeutics, Inc. (PSTV)

Table 1. Insider trading of Insight Molecular Diagnostics Inc. (OCX) by Andrews Ronald Asbury

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-12-01	OCX	Option Ex	250,000	.00	0
2022-08-16	OCX	Buy	40,000	.96	38,400
2022-03-16	OCX	Buy	50,000	1.28	64,149
2021-07-01	OCX	Option Ex	65,000	.00	0
2021-03-19	OCX	Buy	11,000	4.79	52,701
2020-08-03	OCX	Buy	40,000	1.35	53,880
2020-03-30	OCX	Buy	27,216	2.26	61,453
2020-03-31	OCX	Buy	18,000	2,372.00	42,696,000
2018-07-26	OCX	Buy	17,482	.00	0

Table 2. Insider trading of Plus Therapeutics, Inc. (PSTV) by Andrews Ronald Asbury

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-07-01	PSTV	Option Ex	922	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Andrews Ronald Asbury (Officer of Plus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month